MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.carrev.2005.10.007

Медицинская библиотека · Cardiovascular revascularization medicine : including molecular interventions · 2006

Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.

Clavijo Leonardo C, Pinto Tina L, Kuchulakanti Pramod K, Torguson Rebecca, Chu William W, Satler Lowell F, Kent Kenneth M, Suddath William O, Pichard Augusto D, Waksman Ron

СтатьяПеревод в очереди

Аннотация

BACKGROUND

Metabolic syndrome (MS), the combination of hypertension, obesity, dyslipidemia, and insulin resistance, is a precursor of diabetes mellitus (DM) and highly prevalent among patients with acute myocardial infarction (AMI). Diabetes mellitus is associated with larger infarct size and worse outcomes after AMI. This study examined infarct size and short-term outcomes among nondiabetic patients with MS following contemporary treatment of AMI.

METHODS

Four hundred five consecutive patients with AMI treated with primary percutaneous coronary intervention were evaluated. Patients with diabetes (n=105) were excluded. Those with MS (n=167) included patients with three or more of the following criteria: hypertension, elevated fasting blood glucose, hypertriglyceridemia, low high-density lipoprotein, and obesity [body mass index (BMI)> or =30]. The control group (n=133) included patients without MS or DM.

RESULTS

Baseline characteristics were similar except for hypertension, BMI, and dyslipidemia, which by study design were higher in the MS group. The MS group had larger infarct size as determined by peak creatine kinase-MB (79.8+/-133.8 vs. 30.84+/-51.5, P<.001). Overall in-hospital complications were higher in patients with MS (21.1% vs. 9.2%, P=.003). Metabolic syndrome is associated with a 10-fold increased risk of acute renal failure after myocardial infarction (7.9% vs. 0.8%, P=.007).

CONCLUSION

Metabolic syndrome in nondiabetic patients with AMI is associated with larger infarct size, more in-hospital complications, and a marked increase of acute renal failure. Awareness of MS and preventative measures is crucial in this population to minimize infarct size and decrease morbidity after AMI.

Для цитирования: Clavijo Leonardo C, Pinto Tina L, Kuchulakanti Pramod K, Torguson Rebecca, Chu William W, Satler Lowell F, Kent Kenneth M, Suddath William O, Pichard Augusto D, Waksman Ron. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications.. Cardiovascular revascularization medicine : including molecular interventions. 2006. DOI: 10.1016/j.carrev.2005.10.007.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.